Variables | Total (n = 17,772) | Low HDL-C (n = 13,321) | Desirable HDL-C (n = 4,451) | P value |
---|---|---|---|---|
Mean, mg/dL | 36.8 ± 6.1 | 32.9 ± 5.6 | 48.7 ± 7.7 | < 0.001 |
Age, years | 67.2 ± 9.7 | 66.7 ± 9.7 | 68.8 ± 9.5 | < 0.001 |
Female sex | 4674 (26.3%) | 3968 (29.8%) | 706 (15.9%) | < 0.001 |
Diabetes mellitus | 7063 (39.8%) | 5680 (42.7%) | 1383 (31.1%) | < 0.001 |
Hypertension | 9515 (53.5%) | 7320 (55.0%) | 2195 (49.3%) | < 0.001 |
Current smoking | 3155 (17.8%) | 2375 (17.9%) | 780 (17.6%) | 0.661 |
Opium use | 2894 (16.4%) | 2101 (15.9%) | 793 (17.9%) | 0.001 |
FHpCVD | 6501 (36.6%) | 4911 (36.9%) | 1590 (35.7%) | 0.170 |
BMI, kg/m2 | 27.2 ± 4.2 | 27.5 ± 4.2 | 26.4 ± 4.0 | < 0.001 |
Previous MI | 5965 (33.6%) | 4495 (33.7%) | 1470 (33%) | 0.385 |
Previous HF | 490 (2.8%) | 378 (2.9%) | 112 (2.6%) | 0.254 |
CKD | 362 (2%) | 297 (2.2%) | 65 (1.5%) | 0.002 |
COPD | 626 (3.5%) | 461 (3.5%) | 165 (3.7%) | 0.446 |
Previous CVA | 1177 (6.7%) | 882 (6.7%) | 295 (6.7%) | 0.984 |
PAD | 323 (1.8%) | 238 (1.8%) | 85 (1.9%) | 0.596 |
Previous CABG | 88 (0.5%) | 62 (0.5%) | 26 (0.6%) | 0.329 |
Previous PCI | 1337 (7.5%) | 997 (7.5%) | 340 (7.6%) | 0.735 |
LDL-C, mg/dL | 96.4 ± 37.4 | 94.4 ± 36.6 | 102.5 ± 39.2 | < 0.001 |
Triglycerides, mg/dL | 132 (98–180) | 140 (105–190) | 110 (82–148) | < 0.001 |
EF, % | 50 (40–55) | 48 (40–55) | 50 (40–55) | < 0.001 |
Number of grafts | Â | Â | Â | 0.446 |
1 | 338 (1.9%) | 261 (2%) | 77 (1.7%) | |
2 | 1995 (11.2%) | 1486 (11.2%) | 509 (11.4%) | |
3 | 6805 (38.3%) | 5141 (38.6%) | 1664 (37.4%) | |
4 | 7041 (39.6%) | 5254 (39.5%) | 1787 (40.2%) | |
5+ | 1581 (8.9%) | 1169 (8.8%) | 412 (9.3%) | |
OPCAB | 1685 (9.6%) | 1303 (9.9%) | 382 (8.7%) | 0.018 |
ACEi or ARB | 11,896 (69.1%) | 8970 (69.3%) | 2926 (68.2%) | 0.179 |
Statin | 15,600 (89.7%) | 11,719 (89.7%) | 3881 (89.7%) | 0.910 |
Aspirin | 12,413 (72.1%) | 9319 (72%) | 3094 (72.2%) | 0.856 |
Beta Blockers | 14,354 (82.2%) | 10,802 (82.4%) | 3552 (81.7%) | 0.335 |